 MALVERN, Pa., Aug. 11, 2021 GLOBE NEWSWIRE -- TELA Bio, Inc. TELA Nasdaq: TELA, a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today reported second quarter 2021 financial results. 